Antisense therapy for angioplasty restenosis: some critical considerations
MR Bennett, SM Schwartz - Circulation, 1995 - Am Heart Assoc
Percutaneous transluminal angioplasty is now a well-established and frequently performed
procedure that has an initial success rate in reestablishing arterial patency of> 95%. 1 2 …
procedure that has an initial success rate in reestablishing arterial patency of> 95%. 1 2 …
Antisense therapy for angioplasty restenosis. Some critical considerations.
MR Bennett, SM Schwartz - Circulation, 1995 - europepmc.org
The high affinity of even relatively short sequences of DNA for their target mRNA suggests
that antisense agents represent an ideal method of suppressing specific gene products both …
that antisense agents represent an ideal method of suppressing specific gene products both …
Antisense therapy for angioplasty restenosis. Some critical considerations
MR Bennett, SM Schwartz - Circulation, 1995 - pubmed.ncbi.nlm.nih.gov
The high affinity of even relatively short sequences of DNA for their target mRNA suggests
that antisense agents represent an ideal method of suppressing specific gene products both …
that antisense agents represent an ideal method of suppressing specific gene products both …
[引用][C] Antisense therapy for angioplasty restenosis: some critical considerations
MR BENNETT, SM SCHWARTZ - Circulation (New York, NY), 1995 - pascal-francis.inist.fr
Antisense therapy for angioplasty restenosis : some critical considerations CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …